In conclusion, we found that a high expression of IGF2BP3 is associated with a proliferative phenotype in pediatric B-ALL at mRNA and protein levels, and portends a favorable survival high-risk B-ALL. The gene discussed is IGF2BP3; the disease is precursor B-cell acute lymphoblastic leukemia.